Evaluation of immune response in young patients with sarcoma treated by dendritic cell-based immunotherapy

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	FĚDOROVÁ Lenka ZDRAŽILOVÁ DUBSKÁ Lenka SELINGEROVA I. PILÁTOVÁ Kateřina MÚDRY Peter ŠTĚRBA Jaroslav DEMLOVÁ Regina VALÍK Dalibor
Year of publication	2019
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Individually prepared immunotherapy (ITx) based on autologous dendritic cells (DCs) represents a new possibility in modern advanced anti-cancer treatment. As an extended evaluation of DC-based medicinal product in an academic phase I/II clinical trial for children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors (EudraCT 2014-003388-39), we performed the examination of T-cell stimulatory properties and detailed peripheral blood immunomonitoring.
Related projects:	CZECRIN - Český národní uzel Evropské sítě infrastruktur klinického výzkumu